Biodiversity and Health – An International Perspective from A Duke Med Student. This February, supported by a grant from the Duke Medical School Multicultural Resource Center, I traveled to the Second International Conference on Health and Biodiversity (COHAB 2) in Galway, Ireland.
Maria Ines da Silva Barbosa, PhD, began her University Seminar on Global Health on April 1 by talking about a painting. The painting showed four people: a dark-skinned grandmother, wearing typical clothing of a Brazilian domestic servant, and her mixed-blood daughter holding the fair-skinned child fathered by her white husband who was seated next to her.
Every year for the past seven, Dennis Clements, MD, along with faculty and staff from the Schools of Medicine, Nursing, and the Environment, has taken a handful of medical and nursing students to the mountains of Honduras for a week long clinic, part of the “Exploring Medicine in Other Cultures” course at Duke.
Researchers have answered a puzzle about why efforts to lower the transmission of dengue virus in Thailand have not resulted in decreases in the life-threatening form of the infection.
Jeffrey Moe, professor in the Health Sector Management program at Duke’s Fuqua School of Business, takes a look at neglected diseases through the lens of business in the eighth article the Duke Chronicle’s series on global health.
Researchers at Duke and other centers world-wide have found that eltrombopag (marketed as Promacta in the US and Revolade in Europe) boosted platelet counts in a majority of patients with low platelet counts and cirrhosis of the liver due to hepatitis C virus infection. Higher platelet counts enabled most patients to continue or start conventional antiviral treatment. Unlike other drugs that restore normal platelet functions but are given through infusions or injections, eltrombopag is a pill taken just once a day.
More than $45,000 in funding recently was awarded to Duke faculty and staff who submitted proposals earlier in the semester to the Duke Center for Civic Engagement (DCCE) to explore sites around the globe as potential DukeEngage programs in the coming years.
Duane Gubler, an internationally recognized expert on dengue fever, has taken on the post of Director – Emerging Infectious Diseases research program at the Duke-NUS Graduate Medical School in Singapore. His appointment was effective Nov. 1, 2007.
Phil Costanzo writes Duke ChroniclePart 7 in a series on global health in the Duke Chronicle. Obesity is an important focus of global health efforts today because it is a premorbid state that can be preventable with increases in our scientific understanding of the sources of its “spread.”
The stories on the evening news about the tragic health problems that plague people in developing nations can seem very far removed from North Carolina. But when it comes to global health, the world is a small place indeed.